Melanotan II Research for Skin Protection
An evidence-based overview of research examining Melanotan II in the context of skin protection. This page synthesizes findings from peer-reviewed literature.
Research Summary
Melanotan II was originally developed as a potential skin cancer prevention agent. The theory was that stimulated melanin production would provide photoprotection against UV radiation. Increased melanin does provide some protection against UV-induced DNA damage. However, the peptide was never proven to reduce skin cancer risk in clinical trials. The lack of regulatory approval and safety data means Melanotan II cannot be recommended for skin protection. Standard sun protection measures remain the evidence-based approach.
Referenced Studies
Click any PMID to view the full study on PubMed.
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. Melanotan II may have regulatory approval for some indications but should only be used under qualified medical supervision. Always consult a healthcare provider before making health decisions.